Skip to main content
. 2002 Oct 16;2:11. doi: 10.1186/1471-244X-2-11

Table 5.

Haloperidol versus placebo – 1 trial, 40 participants [15]

Main outcomes Hal'dol Placebo RR (95% CI)
Not improved by 2 hours 2/29 4/11 0.19 (0.04–0.9)
Needing another injection Majority in both groups
Mental state: asleep – by 2 hours 1/29 0/11 -
Leaving the study early 0/29 0/11 -
Adverse effects: needing antiparkinsonian medication 6/29 0/11 -